Literature DB >> 11241630

The Type 2 Intramolecular Diels-Alder Reaction: Synthesis and Chemistry of Bridgehead Alkenes.

Brian R. Bear1, Steven M. Sparks, Kenneth J. Shea.   

Abstract

Anti-Bredt alkenes, bicyclic molecules that contain a bridgehead double bond, were for many years regarded as chemical curiosities. The type 2 intramolecular Diels-Alder (IMDA) reaction provides a one-step entry into this fascinating class of molecules. The reaction has made available numerous anti-Bredt alkenes for structural and chemical studies. X-ray crystallography has revealed the magnitude of the deformations associated with the bridgehead double bond, and rate studies of reactions of bridgehead alkenes have allowed quantification of the kinetic consequences of the torsional distortions. More recently, the type 2 intramolecular Diels-Alder reaction and the resulting anti-Bredt alkenes have found application in organic synthesis. The constraints resulting from the connectivity in the Diels-Alder precursor creates a strong regio- and stereochemical bias in the cycloaddition step. The end result of this bias is the stereoselective synthesis of highly substituted six-membered rings. The reaction also achieves a facile synthesis of seven- and eight-membered rings in a single step from acyclic precursors. The utility of this reaction has been verified in recent applications of the type 2 IMDA reaction as a key step in the total synthesis of complex natural products.

Entities:  

Year:  2001        PMID: 11241630

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  15 in total

1.  Type 2 intramolecular N-acylazo Diels-Alder reaction: regio- and stereoselective synthesis of bridgehead bicyclic 1,2-diazines.

Authors:  Claudia L Molina; Chun P Chow; Kenneth J Shea
Journal:  J Org Chem       Date:  2007-08-04       Impact factor: 4.354

Review 2.  Chemistry of bridged lactams and related heterocycles.

Authors:  Michal Szostak; Jeffrey Aubé
Journal:  Chem Rev       Date:  2013-06-17       Impact factor: 60.622

3.  Radical cation Diels-Alder cycloadditions by visible light photocatalysis.

Authors:  Shishi Lin; Michael A Ischay; Charles G Fry; Tehshik P Yoon
Journal:  J Am Chem Soc       Date:  2011-11-11       Impact factor: 15.419

4.  An efficient synthesis of the fully elaborated isoindolinone unit of muironolide A.

Authors:  Qing Xiao; Kyle Young; Armen Zakarian
Journal:  Org Lett       Date:  2013-06-13       Impact factor: 6.005

5.  Visible light photocatalysis of intramolecular radical cation Diels-Alder cycloadditions.

Authors:  Shishi Lin; Christian E Padilla; Michael A Ischay; Tehshik P Yoon
Journal:  Tetrahedron Lett       Date:  2012-04-14       Impact factor: 2.415

6.  Microwave assisted synthesis of bridgehead alkenes.

Authors:  Leah Cleary; Hoseong Yoo; Kenneth J Shea
Journal:  Org Lett       Date:  2011-03-08       Impact factor: 6.005

7.  Origins of regio- and stereochemistry in type 2 intramolecular N-acylnitroso Diels-Alder reactions: a computational study of tether length and substituent effects.

Authors:  Leah Cleary; Victor W Mak; Scott D Rychnovsky; Kenneth J Shea; Nicholas Sizemore
Journal:  J Org Chem       Date:  2013-03-11       Impact factor: 4.354

8.  Enantioselective total synthesis of the reported structures of (-)-9-epi-presilphiperfolan-1-ol and (-)-presilphiperfolan-1-ol: structural confirmation and reassignment and biosynthetic insights.

Authors:  Allen Y Hong; Brian M Stoltz
Journal:  Angew Chem Int Ed Engl       Date:  2012-08-22       Impact factor: 15.336

9.  Improved dienophilicity of nitrocycloalkenes: prospects for the development of a trans-Diels-Alder paradigm.

Authors:  Woo Han Kim; Jun Hee Lee; Samuel J Danishefsky
Journal:  J Am Chem Soc       Date:  2009-09-09       Impact factor: 15.419

10.  Synthesis of the AB subunit of angelmicin B through a tandem alkoxy radical fragmentation-etherification sequence.

Authors:  Jialiang Li; Louis J Todaro; David R Mootoo
Journal:  Org Lett       Date:  2008-03-07       Impact factor: 6.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.